◆英語タイトル：Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1929
◆発行会社（調査会社）：
MarketLine
◆発行日：2018年7月
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report
Summary
Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Bayer HealthCare Pharmaceuticals,(Bayer Healthcare or ‘the company’), a subsidiary of Bayer AG is involved in development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women’s healthcare. The company offers cardiovascular and blood disorder treatment drugs, women healthcare products, contraceptives, erectile dysfunction medicines, testosterone deficiency treatment and ophthalmology products. It also offers oncology products, hematology drug, multiple sclerosis treatment drugs, diabetes treatment drugs, drugs for treatment of infectious diseases (respiratory tract infections, urinary-tract infections, serious skin infections), diagnostic imaging equipment and contrast agents. Bayer Pharma offers its products under brands such as Adalat, Adempas, Aleve, Adengo, Nebido, Xarelto, Xofigo, Yasmin, YAZ among others. It operates through its research and development facilities in Germany, France, China and the US. Bayer HealthCare is headquartered in Berlin, Germany.
Scope
- Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
- An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
- Intelligence on Bayer Healthcare Pharmaceuticals’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bayer Healthcare Pharmaceuticals’s business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 5
Bayer Healthcare Pharmaceuticals: Company Overview 9
Bayer Healthcare Pharmaceuticals: Overview and Key Facts 9
Bayer Healthcare Pharmaceuticals: Overview 9
Bayer Healthcare Pharmaceuticals: Key Facts 9
Bayer Healthcare Pharmaceuticals: Key Employees 10
Bayer Healthcare Pharmaceuticals: Major Products and Services 11
Bayer Healthcare Pharmaceuticals: Company History 13
Bayer Healthcare Pharmaceuticals: Management Statement 19
Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries 23
Bayer Healthcare Pharmaceuticals: Key Competitors 24
Bayer Healthcare Pharmaceuticals: Company Analysis 25
Bayer Healthcare Pharmaceuticals: Business Description 25
Bayer Healthcare Pharmaceuticals: SWOT Analysis 26
Bayer Healthcare Pharmaceuticals: SWOT Overview 26
Bayer Healthcare Pharmaceuticals: Strengths 26
Bayer Healthcare Pharmaceuticals: Weaknesses 27
Bayer Healthcare Pharmaceuticals: Opportunities 27
Bayer Healthcare Pharmaceuticals: Threats 28
Bayer Healthcare Pharmaceuticals: Corporate Financial Deals Activity 30
Bayer Healthcare Pharmaceuticals: Financial Deals Overview 30
Bayer Healthcare Pharmaceuticals: Targets and Partners 31
Bayer Healthcare Pharmaceuticals: Top Deals 2014 – 2018YTD* 32
Bayer Healthcare Pharmaceuticals: Partnership 33
Bayer Healthcare Pharmaceuticals: Recent Developments 34
Bayer Healthcare Pharmaceuticals: News and Events Summary 34
Bayer Healthcare Pharmaceuticals: Corporate Governance 34
Bayer Healthcare Pharmaceuticals: Market Developments 35
Bayer Healthcare Pharmaceuticals: Red Flags/DistressSignals 35
Bayer Healthcare Pharmaceuticals: Research & Development 35
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38
List of Tables
Table 1: Bayer Healthcare Pharmaceuticals: Key Facts
Table 2: Bayer Healthcare Pharmaceuticals: Key Employees
Table 3: Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries
Table 4: Bayer Healthcare Pharmaceuticals: Key Competitors
Table 5: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Bayer Healthcare Pharmaceuticals: Targets and Partners
Table 7: Bayer Healthcare Pharmaceuticals: Top Deals 2014 - 2018YTD*
Table 8: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 9: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 10: Bayer Healthcare Pharmaceuticals: News and Events Summary
Table 11: Bayer Healthcare Pharmaceuticals: Corporate Governance
Table 12: Bayer Healthcare Pharmaceuticals: Market Developments
Table 13: Bayer Healthcare Pharmaceuticals: Red Flags/DistressSignals
Table 14: Bayer Healthcare Pharmaceuticals: Research & Development
List of Figures
Figure 1: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 3: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2014 - YTD*2018)
